DE3486356T2 - Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine. - Google Patents

Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.

Info

Publication number
DE3486356T2
DE3486356T2 DE3486356T DE3486356T DE3486356T2 DE 3486356 T2 DE3486356 T2 DE 3486356T2 DE 3486356 T DE3486356 T DE 3486356T DE 3486356 T DE3486356 T DE 3486356T DE 3486356 T2 DE3486356 T2 DE 3486356T2
Authority
DE
Germany
Prior art keywords
polypeptides
induced
monoclonal antibodies
antibodies against
oncoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3486356T
Other languages
English (en)
Other versions
DE3486356D1 (de
Inventor
Henry L Niman
Richard A Lerner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of DE3486356D1 publication Critical patent/DE3486356D1/de
Application granted granted Critical
Publication of DE3486356T2 publication Critical patent/DE3486356T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DE3486356T 1983-08-17 1984-08-17 Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine. Expired - Lifetime DE3486356T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52408483A 1983-08-17 1983-08-17
PCT/US1984/001304 WO1985000807A1 (en) 1983-08-17 1984-08-17 Polypeptide-induced monoclonal antibodies to oncoproteins

Publications (2)

Publication Number Publication Date
DE3486356D1 DE3486356D1 (de) 1994-12-15
DE3486356T2 true DE3486356T2 (de) 1995-06-01

Family

ID=24087698

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3486356T Expired - Lifetime DE3486356T2 (de) 1983-08-17 1984-08-17 Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.

Country Status (9)

Country Link
EP (2) EP0592026A1 (de)
JP (2) JPS61500068A (de)
AT (1) ATE113962T1 (de)
AU (2) AU580738B2 (de)
CA (1) CA1219232A (de)
DE (1) DE3486356T2 (de)
IT (1) IT1177968B (de)
WO (1) WO1985000807A1 (de)
ZA (1) ZA846439B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972629A (en) 1984-08-17 1999-10-26 The Scripps Research Institute Method for characterizing antigenic reactivity of biological sample
US5591587A (en) * 1983-08-17 1997-01-07 The Scripps Research Institute Polypeptide-induced monoclonal receptors to protein ligands
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US5081230A (en) * 1987-07-08 1992-01-14 E. I. Dupont Denemours And Company Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
CA1296660C (en) * 1985-01-29 1992-03-03 Walter P. Carney Monoclonal antibody against a ras oncogene p21 related dodecapeptide
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US4898932A (en) * 1985-01-29 1990-02-06 E. I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
EP0203587A3 (de) * 1985-05-30 1989-08-09 F. Hoffmann-La Roche Ag Ras-Oncogene-Peptide und Antikörper
EP0206065A3 (de) * 1985-06-27 1989-04-19 James R. Feramisco Verfahren zum Nachweis von oncogenischen und proto-oncogenischen Proteinen in extrazelligen biologischen Flüssigkeiten
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
IL79881A (en) * 1985-08-28 1995-12-08 Pieczenik George Populations of random coding series of oligonucleotides and peptides
JP2726264B2 (ja) * 1986-05-06 1998-03-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｎ‐ｍｙｃタンパク質のためのアッセイ及び抗体
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
JPH02427A (ja) * 1987-07-07 1990-01-05 Max Planck Ges Foerderung Wissenschaft Ev ｃ−ｍｙｂタンパク質のエピトープを認識するモノクローナル抗体、および該抗体を産生するハイブリドーマセルライン
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
EP0370012A1 (de) * 1988-03-08 1990-05-30 E.I. Du Pont De Nemours And Company Monoklonale antikörper, empfänglich für aktivierte und onkogenische ras p21-proteine
ATE154134T1 (de) 1988-04-22 1997-06-15 Oncogene Science Inc Nachweis, quantifizierung und klassifizierung von ras-proteinen in körperflüssigkeiten und geweben
ATE160877T1 (de) * 1988-08-12 1997-12-15 Ligand Pharm Inc Polypeptid-induzierte monoklonale rezeptoren gegen proteinliganden
JP2552047B2 (ja) * 1990-01-26 1996-11-06 ワシントン リサーチ ファウンデーション 悪性腫瘍の検査方法
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3050311C2 (de) * 1980-03-18 1987-06-04 Ciba Geigy Ag Verfahren zur herstellung fester Tr{ger f}r Prote ine zu analytischen Zwecken
EP0103893A3 (de) * 1982-09-22 1986-03-19 Daicel Chemical Industries, Ltd. Macrocyclische Diester
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
NZ220200A (en) * 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
CA1339069C (en) * 1987-11-09 1997-07-29 Henry Lee Niman Polypeptide-induced monoclonal receptors to protein ligand
ATE128716T1 (de) * 1987-11-24 1995-10-15 Abbott Lab Hiv-peptide und methoden für den nachweis von hiv.

Also Published As

Publication number Publication date
IT8448736A1 (it) 1986-02-17
JPH07284398A (ja) 1995-10-31
EP0592026A1 (de) 1994-04-13
IT1177968B (it) 1987-09-03
AU3386089A (en) 1989-08-24
DE3486356D1 (de) 1994-12-15
CA1219232A (en) 1987-03-17
JPS61500068A (ja) 1986-01-16
AU633253B2 (en) 1993-01-28
ZA846439B (en) 1985-03-27
IT8448736A0 (it) 1984-08-17
EP0152477B1 (de) 1994-11-09
AU3395084A (en) 1985-03-12
EP0152477A4 (de) 1987-04-16
AU580738B2 (en) 1989-02-02
EP0152477A1 (de) 1985-08-28
JP2592581B2 (ja) 1997-03-19
ATE113962T1 (de) 1994-11-15
WO1985000807A1 (en) 1985-02-28

Similar Documents

Publication Publication Date Title
DE3486356T2 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
ATE82072T1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
FI895505A0 (fi) Menetelmä ja reagenssipakkaus endotoksiinin tai endotoksiinin kaltaisen aineen määrittämiseksi näytteestä sekä menetelmässä käytettäväksi tarkoitetut monoklonaaliset vasta-aineet
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
ATE55489T1 (de) Hochspezifisches antiserum gegen prokollagenpeptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
ATE123340T1 (de) Diagnostischer nachweis unter verwendung von chimären antikörpern.
NL181461C (nl) Werkwijze en reagenskit voor het bepalen van antigenen, antilichamen of antigeen-antilichaam-complexen of -conjugaten.
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ATE138205T1 (de) Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ATE145480T1 (de) Verfahren zur bestimmung eines analyten
DE58907087D1 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz.
EP0392691A3 (de) Untersuchungen von Wechselwirkungen des Coup-Transkriptionsfaktors
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
ATE40475T1 (de) Verbesserter immunoassay zur bestimmung von antikoerpern gegen native-dna.
DE59007046D1 (de) Verfahren zum Nachweis von Analyten.
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
ATE44980T1 (de) Immunologisches verfahren zum nachweis von brustkrebs durch verwendung von monoklonalen antikoerpern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition